Indoco Company Profile
✉ Email this page to a colleague
What is the competitive landscape for INDOCO, and what generic and branded alternatives to INDOCO drugs are available?
INDOCO has fifteen approved drugs.
There is one tentative approval on INDOCO drugs.
Drugs and US Patents for Indoco
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Indoco | OLANZAPINE | olanzapine | TABLET;ORAL | 206155-004 | Jul 31, 2020 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Indoco | OLANZAPINE | olanzapine | TABLET;ORAL | 206155-006 | Jul 31, 2020 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Indoco | LACOSAMIDE | lacosamide | TABLET;ORAL | 208308-004 | Mar 17, 2022 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Indoco | NEOSTIGMINE METHYLSULFATE | neostigmine methylsulfate | SOLUTION;INTRAVENOUS | 210652-001 | Oct 1, 2021 | AP | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.